CDX2 and intestinal neoplasm: Our findings indicate concurrent Cdx2 silencing combined with BRAFV600E expression in mouse intestinal epithelium leads to premature death of the mice, due to the development of intestinal tumors, including carcinomas, and the tumors recapitulate histological features of human serrated morphology CRCs.